Medifast, Inc. (NYSE:MED) Shares Purchased by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC increased its position in shares of Medifast, Inc. (NYSE:MED) by 2,308.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 11,442 shares of the specialty retailer’s stock after purchasing an additional 10,967 shares during the quarter. Nisa Investment Advisors LLC owned 0.10% of Medifast worth $202,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the company. Bank of Montreal Can purchased a new stake in Medifast during the 2nd quarter worth about $746,000. JPMorgan Chase & Co. lifted its stake in shares of Medifast by 156.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer’s stock valued at $1,100,000 after purchasing an additional 35,017 shares in the last quarter. AQR Capital Management LLC raised its stake in shares of Medifast by 117.5% in the 2nd quarter. AQR Capital Management LLC now owns 389,951 shares of the specialty retailer’s stock valued at $8,509,000 after acquiring an additional 210,669 shares during the period. Millennium Management LLC lifted its holdings in shares of Medifast by 37.8% during the 2nd quarter. Millennium Management LLC now owns 469,216 shares of the specialty retailer’s stock valued at $10,238,000 after acquiring an additional 128,719 shares in the last quarter. Finally, Inspire Investing LLC grew its stake in shares of Medifast by 203.5% in the third quarter. Inspire Investing LLC now owns 48,867 shares of the specialty retailer’s stock valued at $935,000 after buying an additional 32,768 shares in the last quarter. Institutional investors and hedge funds own 95.51% of the company’s stock.

Medifast Stock Performance

Medifast stock opened at $16.01 on Thursday. Medifast, Inc. has a 12 month low of $14.94 and a 12 month high of $57.41. The company has a fifty day moving average price of $17.65 and a two-hundred day moving average price of $18.47. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.11 and a quick ratio of 2.55. The company has a market cap of $175.15 million, a PE ratio of 24.26 and a beta of 1.15.

Medifast (NYSE:MED) last released its quarterly earnings data on Monday, November 4th. The specialty retailer reported $0.35 earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.50. Medifast had a net margin of 1.09% and a return on equity of 15.98%. The firm had revenue of $140.16 million for the quarter, compared to analyst estimates of $135.45 million. During the same quarter in the prior year, the business earned $2.12 earnings per share. Research analysts expect that Medifast, Inc. will post 1.68 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, DA Davidson upgraded Medifast from an “underperform” rating to a “neutral” rating and raised their target price for the company from $16.50 to $17.00 in a research note on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.